/
CRMD
$8.11+$1.04 (+14.65%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$557.0M
78M shares
52-week range
$6.13 – $14.96
22% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change+$2.15
CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
www.cormedix.com- Employees
- 191
- IPO / List date
- May 13, 2010
- HQ
- PARSIPPANY, NJ
Held by traders on TradeandTell
No one on the platform currently holds CRMD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 152,200 | $1.9M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2019-03-26 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded CRMD yet.
